Jiangxi Fushine Pharmaceutical Co Ltd Financial Flexibility Index
Jiangxi Fushine Pharmaceutical Co Ltd financial flexibility index. Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥61.36 Million (operating CF CN¥18.31 Million minus capex CN¥43.04 Million) represents 0% of total liabilities (CN¥2.27 Billion). Explore reinvestment intensity of Jiangxi Fushine Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Financial flexibility index of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Jiangxi Fushine Pharmaceutical Co Ltd across 15 annual periods. Check 300497 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Jiangxi Fushine Pharmaceutical Co Ltd Financial Flexibility Index by Year (2011–2025)
Jiangxi Fushine Pharmaceutical Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Jiangxi Fushine Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangxi Fushine Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥287.56 Million | CN¥62.67 Million | CN¥2.20 Billion | ▼ -6.5% |
| 2024 | 0.14x | CN¥329.39 Million | CN¥187.64 Million | CN¥2.36 Billion | ▲ +84.7% |
| 2023 | 0.08x | CN¥177.46 Million | CN¥-64.76 Million | CN¥2.35 Billion | ▼ -47.1% |
| 2022 | 0.14x | CN¥338.56 Million | CN¥-120.85 Million | CN¥2.37 Billion | ▼ -66.4% |
| 2021 | 0.43x | CN¥751.92 Million | CN¥72.32 Million | CN¥1.77 Billion | ▼ -48.9% |
| 2020 | 0.83x | CN¥831.59 Million | CN¥382.35 Million | CN¥997.93 Million | ▲ +34.3% |
| 2019 | 0.62x | CN¥662.81 Million | CN¥337.91 Million | CN¥1.07 Billion | ▲ +91.7% |
| 2018 | 0.32x | CN¥339.80 Million | CN¥175.91 Million | CN¥1.05 Billion | ▼ -14.0% |
| 2017 | 0.38x | CN¥309.72 Million | CN¥210.72 Million | CN¥822.70 Million | ▼ -14.3% |
| 2016 | 0.44x | CN¥269.87 Million | CN¥188.53 Million | CN¥614.20 Million | ▲ +22.9% |
| 2015 | 0.36x | CN¥147.75 Million | CN¥74.01 Million | CN¥413.44 Million | ▲ +49.9% |
| 2014 | 0.24x | CN¥83.25 Million | CN¥31.39 Million | CN¥349.09 Million | ▼ -44.1% |
| 2013 | 0.43x | CN¥132.82 Million | CN¥57.22 Million | CN¥311.55 Million | ▲ +8.7% |
| 2012 | 0.39x | CN¥114.44 Million | CN¥63.20 Million | CN¥291.70 Million | ▼ -21.5% |
| 2011 | 0.50x | CN¥116.01 Million | CN¥33.80 Million | CN¥232.04 Million | — |